Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Ivermectin and Cancer Stem Cells
Ivermectin and Cancer Stem Cells: Can This Repurposed Drug Target the Root of Tumor Growth? Emerging research suggests ivermectin may target cancer stem cells—the drivers of recurrence and resistance. Learn the science, mechanisms, and clinical implications.
It is theorized that it is cancer stem cells that cause cancer to relapse. Surgery, chemotherapy, and radiation do a pretty good job of ridding your body of cancer, but the cancer stem cells floating around in your bloodstream are what can cause your cancer to come back. The real challenge, then, is to rid the body of cancer stem cells to allow cancer survivors to be truly cancer-free.
When my onc told me that I was end-stage, I searched high and low for cancer therapies that might help me manage my end-stage cancer. I understand the feeling that cancer patients might have when conventional oncology has let them down.
I have researched and written about repurposed drugs for cancer in an effort to provide research for cancer patients considering these therapies to manage their cancer. Please understand the risks and benefits before undergoing any cancer therapy.
Before I get to ivermectin as a cancer therapy, I would like to stress the idea of preparing your body for whatever cancer treatment you choose:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.
Good luck,
David Emerson
Ivermectin to Treat Cancer? Get the FACTS
What Are Cancer Stem Cells and Why Do They Matter?
Cancer stem cells (CSCs) are a small subset of tumor cells responsible for:
- Tumor initiation
- Treatment resistance
- Cancer recurrence and metastasis
Unlike regular cancer cells, CSCs can self-renew and regenerate tumors after chemotherapy or radiation—making them a critical therapeutic target.
Does Ivermectin Target Cancer Stem Cells?
Preclinical research shows that ivermectin may:
- Selectively inhibit cancer stem-like cells
- Reduce expression of “stemness” genes (Nanog, Oct4, Sox2)
- Disrupt tumor growth pathways linked to CSC survival
However, this evidence is primarily laboratory-based, not yet confirmed in large human trials.
What Is Ivermectin?
Ivermectin is a well-known antiparasitic drug used worldwide for decades. Researchers are now studying it as a repurposed cancer therapy due to its:
- Favorable safety profile
- Low cost
- Multi-pathway anticancer activity
The Science: Ivermectin and Cancer Stem Cells
1. Direct Targeting of Cancer Stem Cells
A key study in breast cancer found that ivermectin:
- Preferentially inhibited cancer stem-like cells (CD44+/CD24− populations)
- Reduced tumor spheroid formation (a CSC hallmark)
- Suppressed stemness-related genes
👉 PubMed (clean link):
https://pubmed.ncbi.nlm.nih.gov/29257278/
This is important because CSCs are often resistant to chemotherapy, meaning targeting them could reduce relapse risk.
2. Downregulation of Stemness Pathways
Ivermectin appears to suppress key transcription factors:
- Nanog – self-renewal
- Oct4 – pluripotency
- Sox2 – stem cell maintenance
By reducing these signals, ivermectin may push CSCs out of their stem-like state, making them more vulnerable to treatment.
3. Multi-Pathway Anticancer Effects
Beyond CSC targeting, ivermectin affects multiple cancer pathways:
- Inhibits proliferation and metastasis
- Blocks angiogenesis
- Induces apoptosis and autophagy
- Modulates PAK1 signaling
👉 Review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7505114/
These overlapping mechanisms are why ivermectin is considered a “multi-target” anticancer agent.
4. Potential Synergy With Conventional Therapy
Emerging research suggests ivermectin may:
- Sensitize resistant tumors
- Enhance immunotherapy response
- Improve chemotherapy effectiveness
A clinical trial is currently evaluating ivermectin combined with pembrolizumab in aggressive breast cancer:
👉 Clinical trial listing:
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-02421
Why Targeting Cancer Stem Cells Matters
Most conventional therapies kill bulk tumor cells, but leave CSCs behind.
This can lead to:
- Tumor regrowth
- Metastasis
- Drug resistance
Targeting CSCs is considered one of the most important frontiers in oncology, because eliminating them may:
- Improve long-term survival
- Reduce recurrence
- Enhance treatment durability
Limitations: What the Research Does NOT Yet Show
While the science is promising, it’s critical to understand:
- Most ivermectin-CSC research is in vitro (lab studies)
- Human clinical evidence is limited and ongoing
- Effective dosing for cancer is not established
Even major cancer organizations emphasize that lab findings do not automatically translate into real-world outcomes
Integrative Oncology Perspective
From an integrative cancer standpoint, ivermectin fits into a broader strategy:
Potential Role
- Repurposed drug targeting CSC biology
- Adjunct to conventional therapy (not replacement)
Complementary Strategies That Also Target CSCs
- Curcumin (NF-kB, STAT3 inhibition)
- EGCG (green tea)
- Sulforaphane (broccoli sprouts)
- Ketogenic/metabolic therapies
Key Takeaways
- Cancer stem cells drive recurrence and resistance
- Ivermectin shows selective activity against CSCs in lab studies
- It works by:
- Suppressing stemness genes
- Disrupting survival pathways
- Enhancing treatment sensitivity
Clinical evidence is still emerging, not definitive
To Learn More:
To build topical authority, link this post to:
Pillar Pages
- Ivermectin and Cancer: What the Research Really Shows
- Repurposed Drugs in Cancer Therapy
- Complementary Cancer Therapies